Literature DB >> 26738203

Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".

Jens Petter Bakkehaug1, Anders Benjamin Kildal1, Eirik Torgersen Engstad1, Neoma Boardman1, Torvind Næsheim2, Leif Rønning1, Ellen Aasum1, Terje S Larsen1, Truls Myrmel3, Ole-Jakob How1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26738203     DOI: 10.1161/CIRCHEARTFAILURE.115.002548

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  3 in total

1.  Treatments targeting inotropy.

Authors:  Christoph Maack; Thomas Eschenhagen; Nazha Hamdani; Frank R Heinzel; Alexander R Lyon; Dietmar J Manstein; Joseph Metzger; Zoltán Papp; Carlo G Tocchetti; M Birhan Yilmaz; Stefan D Anker; Jean-Luc Balligand; Johann Bauersachs; Dirk Brutsaert; Lucie Carrier; Stefan Chlopicki; John G Cleland; Rudolf A de Boer; Alexander Dietl; Rodolphe Fischmeister; Veli-Pekka Harjola; Stephane Heymans; Denise Hilfiker-Kleiner; Johannes Holzmeister; Gilles de Keulenaer; Giuseppe Limongelli; Wolfgang A Linke; Lars H Lund; Josep Masip; Marco Metra; Christian Mueller; Burkert Pieske; Piotr Ponikowski; Arsen Ristić; Frank Ruschitzka; Petar M Seferović; Hadi Skouri; Wolfram H Zimmermann; Alexandre Mebazaa
Journal:  Eur Heart J       Date:  2019-11-21       Impact factor: 29.983

Review 2.  Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.

Authors:  Tariq Ahmad; P Elliott Miller; Megan McCullough; Nihar R Desai; Ralph Riello; Mitchell Psotka; Michael Böhm; Larry A Allen; John R Teerlink; Giuseppe M C Rosano; Joann Lindenfeld
Journal:  Eur J Heart Fail       Date:  2019-08-13       Impact factor: 15.534

3.  Protective effects of recombinant human brain natriuretic peptide in perioperative period during open heart surgery.

Authors:  Yunbin Xu; Yong Li; Weiguo Bao; Shi Qiu
Journal:  Exp Ther Med       Date:  2018-01-12       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.